On Target with Dr Akila Viswanathan - Personalized Dose for Seminars in Radiation Oncology

Johns Hopkins Kimmel Cancer Center

Контент предоставлен Johns Hopkins Kimmel Cancer Center. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Johns Hopkins Kimmel Cancer Center или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

2M ago 28:38

MP3•Главная эпизода

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 29, 2024 09:56 (13d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

In this On Target podcast, Dr Akila Viswanathan, Director of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins Kimmel Cancer Center, speaks with Dr. Deborah Citrin from the National Cancer Institute’s Center for Cancer Research and Dr. Zachary Morris from the University of Wisconsin School of Medicine and Public Health for an issue of Seminars in Radiation Oncology focusing on personalized dose.

The discussion explores advancements in radiation therapy, including how modern technology and biology are being used to tailor radiotherapy doses to individual patients. Dr Citrin highlights the potential of integrating genomics, imaging, and biomarkers to achieve personalized treatment, while Dr Morris examines disease-specific biomarkers and their application in clinical practice.

This episode covers key topics such as using gene expression signatures to predict radiation response, leveraging imaging for adaptive therapy, and how molecular markers are helping to refine treatment decisions. They also explore the promise of circulating tumor DNA as a tool for guiding radiation dosage and the complexities of combining radiation with immunotherapy.

120 эпизодов

#Akilavviswanathan #Benlevy #Billnelson #Cancer #Cancervdisparitites #Integrativemedicine #Johnshopkins #Kimmelcancercenter #Otisvbrawley #Fitness #Johns Hopkins Kimmel Cancer Center #Oncology #Science #Medicine #Ashwanirajput #Washingtondc